CTCBIO Inc. (KOSDAQ:060590)

South Korea · Delayed Price · Currency is KRW

4,320.00

+70.00 (1.65%)

At close: Feb 20, 2026

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Consolidation Adjustments	-8.61B	-5.25B	-8.60B	-3.74B	-1.62B
Animal and Human Medicine Sale	127.63B	116.35B	139.44B	114.19B	103.29B
Animal and Human Medicine Sale Growth	9.69%	-16.56%	22.12%	10.55%	-4.62%
Hay Sale	24.53B	24.93B	32.90B	29.67B	28.36B
Hay Sale Growth	-1.62%	-24.22%	10.90%	4.63%	-9.24%
Health Functional Food Sales	859.05M	1.85B	1.45B	199.89M	-
Health Functional Food Sales Growth	-53.51%	27.20%	626.67%	-	-
Total	144.41B	137.88B	165.21B	140.32B	130.03B
Total Growth	4.74%	-16.54%	17.74%	7.91%	-4.48%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
South Korea	152.07B	141.28B	172.35B	143.86B	131.65B
South Korea Growth	7.63%	-18.02%	19.80%	9.27%	-5.66%
Overseas	950.43M	1.85B	1.45B	199.89M	-
Overseas Growth	-48.56%	27.20%	626.67%	-	-
Consolidated Adjustments	-8.61B	-5.25B	-8.60B	-3.74B	-1.62B
Total	144.41B	137.88B	165.21B	140.32B	130.03B
Total Growth	4.74%	-16.54%	17.74%	7.91%	-4.48%

Source: S&P Global Market Intelligence.